150 related articles for article (PubMed ID: 31955813)
1. The association of preoperative thyroid-stimulating hormone level and the risk of differentiated thyroid cancer in patients with thyroid nodules: A systematic review and meta-analysis.
Su A; Zhao W; Wu W; Wei T; Ruan M; Li Z; Zhu J
Am J Surg; 2020 Sep; 220(3):634-641. PubMed ID: 31955813
[TBL] [Abstract][Full Text] [Related]
2. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
Zafón C; Obiols G; Mesa J
Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
[TBL] [Abstract][Full Text] [Related]
3. Preoperative thyroid-stimulating hormone associated risk of differentiated thyroid cancer in patients with thyroid nodules.
M AE
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):85-91. PubMed ID: 34933729
[TBL] [Abstract][Full Text] [Related]
4. Serum thyrotropin concentration in children with isolated thyroid nodules.
Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of serum thyrotropin for risk prediction of differentiated thyroid cancers does not apply to microcarcinomas: results of 1,870 Chinese patients with thyroid nodules.
Shi L; Li Y; Guan H; Li C; Shi L; Shan Z; Teng W
Endocr J; 2012; 59(11):973-80. PubMed ID: 22785429
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
[TBL] [Abstract][Full Text] [Related]
9. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
[TBL] [Abstract][Full Text] [Related]
10. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
Haymart MR; Repplinger DJ; Leverson GE; Elson DF; Sippel RS; Jaume JC; Chen H
J Clin Endocrinol Metab; 2008 Mar; 93(3):809-14. PubMed ID: 18160464
[TBL] [Abstract][Full Text] [Related]
11. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
[TBL] [Abstract][Full Text] [Related]
12. An overall and dose-response meta-analysis for thyrotropin and thyroid cancer risk by histological type.
Hu N; Li ZM; Liu JF; Zhang ZZ; Wang LS
Oncotarget; 2016 Jul; 7(30):47750-47759. PubMed ID: 27351286
[TBL] [Abstract][Full Text] [Related]
13. Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
Kim H; Jung J; Cho YS; Choi JY; Park H; Lee YB; Kim SW; Chung JH; Kim TH
Sci Rep; 2021 Nov; 11(1):22322. PubMed ID: 34785735
[TBL] [Abstract][Full Text] [Related]
14. The Usefulness of Preoperative Thyroid-Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma.
Shi RL; Liao T; Qu N; Liang F; Chen JY; Ji QH
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):256-62. PubMed ID: 26598500
[TBL] [Abstract][Full Text] [Related]
15. High Serum Thyrotropin Concentrations within the Reference Range: A Predictor of Malignancy in Nodular Thyroid Disease.
Duccini K; de Souza MVL; Delfim R; Aguiar AP; Teixeira P; Vaisman M
Med Princ Pract; 2018; 27(3):272-277. PubMed ID: 29514150
[TBL] [Abstract][Full Text] [Related]
16. Higher TSH level is a risk factor for differentiated thyroid cancer.
Kim HK; Yoon JH; Kim SJ; Cho JS; Kweon SS; Kang HC
Clin Endocrinol (Oxf); 2013 Mar; 78(3):472-7. PubMed ID: 22924613
[TBL] [Abstract][Full Text] [Related]
17. Higher TSH Is Not Associated With Thyroid Cancer Risk in the Presence of Thyroid Autoimmunity.
Paparodis RD; Bantouna D; Karvounis E; Imam S; Jaume JC
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32391913
[TBL] [Abstract][Full Text] [Related]
18. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
Moon SS; Lee YS; Lee IK; Kim JG
Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
[TBL] [Abstract][Full Text] [Related]
19. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
[TBL] [Abstract][Full Text] [Related]
20. [Association between the serum TSH concentration and thyroid cancer incidence].
Li JZ; Jin YJ; Liu X; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
